| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.30B | 11.17B | 9.35B | 10.03B | 10.45B | 7.36B |
| Gross Profit | 4.22B | 4.25B | 2.58B | 3.46B | 4.55B | 2.69B |
| EBITDA | 1.25B | 1.58B | 579.65M | 1.04B | 1.81B | 500.81M |
| Net Income | 470.50M | 911.88M | -408.66M | 45.29M | 1.55B | 87.12M |
Balance Sheet | ||||||
| Total Assets | 16.32B | 15.93B | 15.98B | 16.20B | 14.61B | 11.30B |
| Cash, Cash Equivalents and Short-Term Investments | 2.36B | 2.41B | 2.69B | 2.61B | 2.39B | 3.02B |
| Total Debt | 6.09B | 5.34B | 6.37B | 6.01B | 4.09B | 5.11B |
| Total Liabilities | 8.13B | 7.47B | 8.49B | 8.20B | 6.52B | 6.93B |
| Stockholders Equity | 8.19B | 8.46B | 7.48B | 8.00B | 8.09B | 4.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 915.12M | -178.77M | -1.42B | -1.70B | -375.25M |
| Operating Cash Flow | 0.00 | 1.60B | 451.87M | -423.12M | 1.66B | -114.49M |
| Investing Cash Flow | 0.00 | -695.59M | -633.76M | -1.07B | -3.34B | -225.17M |
| Financing Cash Flow | 0.00 | -1.06B | 144.43M | 1.64B | 932.90M | 575.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥116.72B | 10.07 | ― | 3.72% | 4.93% | 30.22% | |
76 Outperform | ¥77.09B | 6.04 | ― | 3.04% | -0.11% | -31.90% | |
76 Outperform | ¥16.85B | 9.34 | ― | 2.29% | 6.48% | -25.01% | |
75 Outperform | ¥757.87B | 17.03 | 12.15% | 1.58% | 3.12% | -0.65% | |
72 Outperform | ¥1.94T | 15.54 | 11.98% | 1.54% | 1.41% | 0.76% | |
69 Neutral | ¥557.12B | 23.07 | ― | 3.26% | 15.83% | 124.18% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |